| Nanobody‐engineered natural killer cell conjugates for solid tumor adoptive immunotherapy L Gong, Y Li, K Cui, Y Chen, H Hong, J Li, D Li, Y Yin, Z Wu, Z Huang Small 17 (45), 2103463, 2021 | 33 | 2021 |
| Site-specific C-terminal dinitrophenylation to reconstitute the antibody Fc functions for nanobodies H Hong, Z Zhou, K Zhou, S Liu, Z Guo, Z Wu Chemical Science 10 (40), 9331-9338, 2019 | 26 | 2019 |
| Efficient expression of sortase A from Staphylococcus aureus in Escherichia coli and its enzymatic characterizations Z Wu, H Hong, X Zhao, X Wang Bioresources and Bioprocessing 4, 1-10, 2017 | 26 | 2017 |
| Rhamnose modified bovine serum albumin as a carrier protein promotes the immune response against sTn antigen H Lin, H Hong, J Wang, C Li, Z Zhou, Z Wu Chemical Communications 56 (90), 13959-13962, 2020 | 23 | 2020 |
| Universal endogenous antibody recruiting nanobodies capable of triggering immune effectors for targeted cancer immunotherapy H Hong, C Li, L Gong, J Wang, D Li, J Shi, Z Zhou, Z Huang, Z Wu Chemical Science 12 (12), 4623-4630, 2021 | 19 | 2021 |
| One-step purification and immobilization of extracellularly expressed sortase A by magnetic particles to develop a robust and recyclable biocatalyst X Zhao, H Hong, X Cheng, S Liu, T Deng, Z Guo, Z Wu Scientific Reports 7 (1), 6561, 2017 | 18 | 2017 |
| Chemoenzymatic Synthesis of a Rhamnose‐Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy H Hong, H Lin, D Li, L Gong, K Zhou, Y Li, H Yu, K Zhao, J Shi, Z Zhou, ... Angewandte Chemie 134 (38), e202208773, 2022 | 15 | 2022 |
| High yield synthesis of cyclic analogues of antibacterial peptides P-113 by Sortase A-mediated ligation and their conformation studies ZM Wu, SZ Liu, XZ Cheng, XR Zhao, HF Hong Chinese Chemical Letters 28 (3), 553-557, 2017 | 15 | 2017 |
| MUC1 vaccines using β-cyclodextrin grafted chitosan (CS-g-CD) as carrier via host-guest interaction elicit robust immune responses H Yu, H Lin, Y Xie, M Qu, M Jiang, J Shi, H Hong, H Xu, L Li, G Liao, Z Wu, ... Chinese Chemical Letters 33 (11), 4882-4885, 2022 | 13 | 2022 |
| Nanobody-Based Bispecific Neutralizer for Shiga Toxin-Producing E. coli Z Lu, Z Liu, X Li, X Qin, H Hong, Z Zhou, RJ Pieters, J Shi, Z Wu ACS Infectious Diseases 8 (2), 321-329, 2022 | 13 | 2022 |
| One-step immobilization and purification of genetic engineering CBD fusion EndoS on cellulose for antibodies Fc-glycan remodeling K Zhao, F Tang, W Shi, H Hong, Z Zhou, W Huang, Z Wu Bioorganic Chemistry 91, 103114, 2019 | 13 | 2019 |
| Enzymatic on-resin peptide cleavage and in situ cyclization one-pot strategy for the synthesis of cyclopeptide and cyclotide X Cheng, H Hong, Z Zhou, Z Wu The Journal of Organic Chemistry 83 (22), 14078-14083, 2018 | 13 | 2018 |
| Chemical Synthesis of Antibody–Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer Immunotherapy K Zhou, HF Hong, H Lin, L Gong, D Li, J Shi, Z Zhou, F Xu, Z Wu Journal of Medicinal Chemistry 65 (1), 323-332, 2021 | 12 | 2021 |
| Sortase A-mediated on-resin peptide cleavage and in situ ligation: an efficient one-pot strategy for the synthesis of functional peptides and proteins X Cheng, T Zhu, H Hong, Z Zhou, Z Wu Organic Chemistry Frontiers 4 (10), 2058-2062, 2017 | 12 | 2017 |
| New potent and selective αvβ3 integrin ligands: Macrocyclic peptides containing RGD motif synthesized by sortase A-mediated ligation Z Wu, X Cheng, H Hong, X Zhao, Z Zhou Bioorganic & medicinal chemistry letters 27 (9), 1911-1913, 2017 | 12 | 2017 |
| Dinitrophenol-mediated modulation of an anti-PD-L1 VHH for Fc-dependent effector functions and prolonged serum half-life J Liu, H Hong, J Shi, Y Xie, Z Lu, Z Liu, Z Zhou, Z Bian, Z Huang, Z Wu European Journal of Pharmaceutical Sciences 165, 105941, 2021 | 10 | 2021 |
| Synthesis of DNP-modified GM3-based anticancer vaccine and evaluation of its immunological activities for cancer immunotherapy H Lin, H Hong, L Feng, J Shi, Z Zhou, Z Wu Chinese Chemical Letters 32 (12), 4041-4044, 2021 | 9 | 2021 |
| Exendin 4-hapten conjugate capable of binding with endogenous antibodies for peptide half-life extension and exerting long-acting hypoglycemic activity S Dai, H Hong, K Zhou, K Zhao, Y Xie, C Li, J Shi, Z Zhou, L Nie, Z Wu Journal of Medicinal Chemistry 64 (8), 4947-4959, 2021 | 8 | 2021 |
| Dinitrophenol‐Hyaluronan Conjugates as Multivalent Antibody‐Recruiting Glycopolymers for Targeted Cancer Immunotherapy H Lin, K Zhou, D Li, H Hong, Y Xie, L Gong, Y Shen, Z Zhou, J Shi, Z Wu ChemMedChem 16 (19), 2960-2968, 2021 | 6 | 2021 |
| β-Galactosidase-dependent metabolic glycoengineering of tumor cells for imaging and immunotherapy Y Li, L Gong, H Hong, H Lin, D Li, J Shi, Z Zhou, Z Wu Chemical Communications 58 (15), 2568-2571, 2022 | 5 | 2022 |
